BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20154275)

  • 1. Immunohistochemical evaluation of p16INK4A, E-cadherin, and cyclin D1 expression in melanoma and Spitz tumors.
    George E; Polissar NL; Wick M
    Am J Clin Pathol; 2010 Mar; 133(3):370-9. PubMed ID: 20154275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
    Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
    J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle and apoptosis regulators in Spitz nevi: comparison with melanomas and common nevi.
    Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Patereli A; Stratigos A; Katsambas A
    J Am Acad Dermatol; 2007 May; 56(5):815-24. PubMed ID: 17437889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
    Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA
    Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma.
    Hilliard NJ; Krahl D; Sellheyer K
    J Cutan Pathol; 2009 Jul; 36(7):753-9. PubMed ID: 19519606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
    Garola R; Singh V
    Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
    Isabel Zhu Y; Fitzpatrick JE
    J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9p21 gene locus in Spitz nevi of older individuals: absence of cytogenetic and immunohistochemical findings associated with malignancy.
    Horst BA; Terrano D; Fang Y; Silvers DN; Busam KJ
    Hum Pathol; 2013 Dec; 44(12):2822-8. PubMed ID: 24134932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion.
    Takata M; Lin J; Takayanagi S; Suzuki T; Ansai S; Kimura T; Cerroni L; Saida T
    Br J Dermatol; 2007 Jun; 156(6):1287-94. PubMed ID: 17535228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of established and new criteria in differential diagnosis of Spitz nevus and melanoma.
    Ritter A; Tronnier M; Vaske B; Mitteldorf C
    Arch Dermatol Res; 2018 May; 310(4):329-342. PubMed ID: 29417221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
    Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
    Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
    Demirkan NC; Bir F; Erdem O; Düzcan E
    J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient age in Spitz nevus and malignant melanoma: implication of Bayes rule for differential diagnosis.
    Vollmer RT
    Am J Clin Pathol; 2004 Jun; 121(6):872-7. PubMed ID: 15198360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Spitz nevus. Spindle cell and/or epithelioid cell nevus--a histological analysis of 652 tumors].
    Gartmann H; Ganser M
    Z Hautkr; 1985 Jan; 60(1-2):29-30, 34-6, 39-42. PubMed ID: 3984434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acral Spitz Nevi: A Clinicopathologic Study of 50 Cases With Immunohistochemical Analysis of P16 and P21 Expression.
    Wiedemeyer K; Guadagno A; Davey J; Brenn T
    Am J Surg Pathol; 2018 Jun; 42(6):821-827. PubMed ID: 29537991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic prediction of the immunohistochemical expression of p16 and p53 in cutaneous melanoma: a comparison of two populations from different geographical regions.
    Sirigu P; Piras F; Minerba L; Murtas D; Maxia C; Colombari R; Corbu A; Perra MT; Ugalde J
    Eur J Histochem; 2006; 50(3):191-8. PubMed ID: 16920642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy in patients with "atypical Spitz tumors." A report on 12 cases.
    Urso C; Borgognoni L; Saieva C; Ferrara G; Tinacci G; Begliomini B; Reali UM
    Hum Pathol; 2006 Jul; 37(7):816-23. PubMed ID: 16784980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.